Glynux 1 Tablet is primarily indicated for managing adult type 2 diabetes mellitus, a metabolic disorder characterised by impaired insulin utilisation. This oral medicine belongs to the class of medications known as sulfonylureas.
Glynux 1 Tablet is prescribed for:
• Managing type 2 diabetes mellitus in adults
• Regulating blood glucose levels to avoid diabetes-related complications
• Swallow the tablet whole without chewing or crushing it.
• Take this medication with or immediately after a meal.
• Do not exceed the prescribed dose without consulting your doctor.
• Consult your doctor before discontinuing the medicine.
Glynux 1 Tablet is taken orally.
The side effects of this tablet include:
• Hypoglycaemia (low blood sugar levels)
• Headache
• Nausea
• Dizziness
• Weakness
Glynux 1 Tablet contains glimepiride (1 mg), which functions as follows:
• Binds to Sulfonylurea Receptors: Glimepiride attaches to specific receptors on pancreatic beta cells, which are responsible for insulin production.
• Insulin Release: This binding initiates a cascade of events leading to increased insulin release from the pancreatic beta cells.
• Blood Glucose Reduction: The additional insulin facilitates glucose uptake in peripheral tissues, such as skeletal muscle, and decreases hepatic glucose output, thus lowering blood glucose levels.
Not recommended.
Not recommended.
Alcohol consumption may alter blood glucose levels.
Caution is advised.
Caution is advised.
The medicine may cause dizziness or weakness; exercise caution when driving or operating machinery.
This tablet should not be taken by those with known allergies to glimepiride, sulfonylureas, or sulfonamides.
This tablet is intended for adult use and should not be administered to individuals under 18 years.
Elderly individuals may be more sensitive to the side effects and should take the medicine under medical supervision.
Drug-Drug Interactions
Glynux 1 Tablet interacts with:
• Beta-blockers: May affect the glucose-lowering effect of glimepiride.
• Salicylates: Can enhance the glucose-lowering effect when co-administered with this tablet.
• Sulfonamides: May potentiate the hypoglycaemic effect of this tablet.
• Monoamine Oxidase Inhibitors (MAOIs): May amplify the blood sugar-lowering effect.
Daily Dosage
• This tablet should be taken as advised by your doctor. The dosage depends on your health condition and response to medication.
Missed Dose
• If you forget to take your dose, consume it as soon as you remember. If it is nearly time for the next dose, skip the missed one and continue with your regular schedule. Do not double the dose.
Overdose
Symptoms of this tablet overdose may include:
• Dizziness
• Headache
• Weakness
• Store this tablet in a dry place, away from light.
• Maintain an ideal temperature below 30°C.
• Keep the medicine out of reach of children and pets.
• Use the medicine before its expiry date for maximum efficacy.
• Regularly monitor your blood glucose levels to understand how various factors affect your diabetes management.
• Maintain a balanced diet rich in fibre, whole grains, fruits, and vegetables.
• Avoid foods high in sugar to prevent blood glucose spikes.
.avif)
%20(1).png)
.webp)